Citations

Clear

2960 citation(s) found for "Kim, P".

How image quality affects determination of target displacement when using kilovoltage cone‐beam computed tomography
Oh, Seungjong, Suh, Tae‐Suk, Kim, Siyong

Mayo Clinic

Journal of Applied Clinical Medical Physics | June 7, 2007 | Volume: 8 | Issue: 1 | Pages: 101-107

10.1120/jacmp.v8i1.2440 | PMID 17592455 Get It

The advent of kilovoltage cone‐beam computed tomography (CBCT) integrated with a linear accelerator allows for more accurate image‐guided radiotherapy (IGRT). The IGRT technique corrects target displacement based on internal body information obtained by acquiring the CBCT image set and registering it with the simulation CT image set just before the beam is delivered. In the present paper, we compare registration results by CBCT reconstruction quality (either high or medium). We analyzed data from a total of 56 CBCT projections from 6 patients. The translational vector differences were within 1 mm in all but 3 cases. The rotational displacement differences considered components of all three axes, and in 3 of 168 cases (56 projections by 3 axes), showed more than 1 degree of difference.PACS number: 87.57.Nk
Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Can
Olsen, Elise A. , Vonderheid, Eric C. , Pimpinelli, Nicola , Knobler, Robert , Zackheim, Herschel, Estrach, Teresa , Lamberg, Stanford, Wood, Gary S. , Dummer, Reinhard , Burg, Günter , Heald, Peter, Pittelkow, Mark R. , Bernengo, M.G., Sterry, Wolfram, Laroche, L. , Trautinger, Franz , Whittaker, Sean , Willemze, Rein , Kim, Youn , Zackheim, Herschel, Duvic, Madeleine , Lamberg, Stanford, Ranki, Annamari , Sterry, Wolfram

Mayo Clinic

Blood | May 31, 2007 | Volume: 110 | Issue: 6 | Pages: 1713-1722

10.1182/blood-2007-03-055749 | PMID 17540844 Get It

Abstract The ISCL/EORTC recommends revisions to the Mycosis Fungoides Cooperative Group classification and staging system for cutaneous T-cell lymphoma (CTCL). These revisions are made to incorporate advances related to tumor cell biology and diagnostic techniques as pertains to mycosis fungoides (MF) and Sézary syndrome (SS) since the 1979 publication of the original guidelines, to clarify certain variables that currently impede effective interinstitution and interinvestigator communication and/or the development of standardized clinical trials in MF and SS, and to provide a platform for tracking other variables of potential prognostic significance. Moreover, given the difference in prognosis and clinical characteristics of the non-MF/non-SS subtypes of cutaneous lymphoma, this revision pertains specifically to MF and SS. The evidence supporting the revisions is discussed as well as recommendations for evaluation and staging procedures based on these revisions.
Molecular Dissection of Hyperdiploid Multiple Myeloma by Gene Expression Profiling
Kumar, Shaji , VanWier, Scott, Ahmann, Greg, Price-Troska, Tammy, Henderson, Kim, Chung, Tae‐Hoon , Kim, Seungchan , Bryant, Barbara M. , Carpten, John D. , Rajkumar, S. Vincent , Lacy, Martha Q. , Dispenzieri, Angela , Kyle, Robert A. , Greipp, Philip R., Bergsagel, P. Leif , Fonseca, Rafaël , Bergsagel, P. Leif , Chng, Wee Joo , Henderson, Kimberly J., Mulligan, George , Gertz, Morie A. , Rajkumar, S Vincent , Dispenzieri, Angela , Chung, Tae-Hoon , Fonseca, Rafael

Mayo Clinic

Cancer Research | April 4, 2007 | Volume: 67 | Issue: 7 | Pages: 2982-2989

10.1158/0008-5472.can-06-4046 | PMID 17409404 Get It

Abstract Hyperdiploid multiple myeloma (H-MM) is the most common form of myeloma. In this gene expression profiling study, we show that H-MM is defined by a protein biosynthesis signature that is primarily driven by a gene dosage mechanism as a result of trisomic chromosomes. Within H-MM, four independently validated patient clusters overexpressing nonoverlapping sets of genes that form cognate pathways/networks that have potential biological importance in multiple myeloma were identified. One prominent cluster, cluster 1, is characterized by high expression of cancer testis antigen and proliferation-associated genes. Tumors from these patients were more proliferative than tumors in other clusters (median plasma cell labeling index, 3.8; P < 0.05). Another cluster, cluster 3, is characterized by genes involved in tumor necrosis factor/nuclear factor-κB signaling and antiapoptosis. These patients have better response to bortezomib as compared with patients within other clusters (70% versus 29%; P = 0.02). Furthermore, for a group of patients generally thought to have better prognosis, a cluster of patients with short survival (cluster 1; median survival, 27 months) could be identified. This analysis illustrates the heterogeneity within H-MM and the importance of defining specific cytogenetic prognostic factors. Furthermore, the signatures that defined these clusters may provide a basis for tailoring treatment to individual patients. [Cancer Res 2007;67(7):2982–9]
Inhibition of caveolar uptake, SV40 infection, and β1-integrin signaling by a nonnatural glycosphingolipid stereoisomer
Singh, Raman Deep , Holicky, Eileen L., Cheng, Zhi-jie Jey , Kim, Seong‐Youl, Wheatley, Christine L., Marks, David L. , Bittman, Robert, Pagano, Richard E.

Mayo Clinic

The Journal of Cell Biology | March 20, 2007 | Volume: 176 | Issue: 7 | Pages: 895-901

10.1083/jcb.200609149 | PMID 17371832 Get It

Caveolar endocytosis is an important mechanism for the uptake of certain pathogens and toxins and also plays a role in the internalization of some plasma membrane (PM) lipids and proteins. However, the regulation of caveolar endocytosis is not well understood. We previously demonstrated that caveolar endocytosis and β1-integrin signaling are stimulated by exogenous glycosphingolipids (GSLs). In this study, we show that a synthetic GSL with nonnatural stereochemistry, β-d-lactosyl-N-octanoyl-l-threo-sphingosine, (1) selectively inhibits caveolar endocytosis and SV40 virus infection, (2) blocks the clustering of lipids and proteins into GSLs and cholesterol-enriched microdomains (rafts) at the PM, and (3) inhibits β1-integrin activation and downstream signaling. Finally, we show that small interfering RNA knockdown of β1 integrin in human skin fibroblasts blocks caveolar endocytosis and the stimulation of signaling by a GSL with natural stereochemistry. These experiments identify a new compound that can interfere with biological processes by inhibiting microdomain formation and also identify β1 integrin as a potential mediator of signaling by GSLs.
Alpha-lipoic acid: effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy.
Kishi, Yutaka, Schmelzer, James D., Yao, Jeffrey , Zollman, Paula J., Nickander, Kim K., Tritschler, Hans, Low, Phillip A.

Mayo Clinic

Diabetes | March 6, 2007 | Volume: 48 | Issue: 10 | Pages: 2045-2051

10.2337/diabetes.48.10.2045 | PMID 10512372 Get It

The peripheral nerve of experimental diabetic neuropathy (EDN) is reported to be ischemic and hypoxic, with an increased dependence on anaerobic metabolism, requiring increased energy substrate stores. When glucose stores become reduced, fiber degeneration has been reported. We evaluated glucose uptake, nerve energy metabolism, the polyol pathway, and protein kinase C (PKC) activity in EDN induced by streptozotocin. Control and diabetic rats received lipoic acid (0, 10, 25, 50, 100 mg/kg). Duration of diabetes was 1 month, and alpha-lipoic acid was administered intraperitoneally 5 times per week for the final week of the experiment. Nerve glucose uptake was reduced to 60, s 37, and 30% of control values in the sciatic nerve, L5 dorsal root ganglion, and superior cervical ganglion (SCG), respectively, in rats with EDN. Alpha-lipoic acid supplementation had no effect on glucose uptake in normal nerves at any dose, but reversed the deficit in EDN, with a threshold between 10 and 25 mg/kg. Endoneurial glucose, fructose, sorbitol, and myo-inositol were measured in sciatic nerve. Alpha-lipoic acid had no significant effect on either energy metabolism or polyol pathway of normal nerves. In EDN, endoneurial glucose, fructose, and sorbitol were significantly increased, while myo-inositol was significantly reduced. Alpha-lipoic acid had a biphasic effect: it dose-dependently increased fructose, glucose, and sorbitol, peaking at 25 mg/kg, and then fell beyond that dose, and it dose-dependently increased myo-inositol. Sciatic nerve cytosolic PKC was increased in EDN. ATP, creatine phosphate, and lactate were measured in sciatic nerve and SCG. Alpha-lipoic acid prevented the reduction in SCG creatine phosphate. We conclude that glucose uptake is reduced in EDN and that this deficit is dose-dependently reversed by alpha-lipoic acid, a change associated with an improvement in peripheral nerve function.
Deficiency of co-chaperone immunophilin FKBP52 compromises sperm fertilizing capacity
Hong, Ji-Young, Kim, Sung Tae , Tranguch, Susanne , Smith, David F. , Dey, Sudhansu K.

Mayo Clinic

Reproduction | February 16, 2007 | Volume: 133 | Issue: 2 | Pages: 395-403

10.1530/rep-06-0180 | PMID 17307907 Get It

Abstract FKBP52 is a member of the FK506-binding family of immunophilins and serves as a co-chaperone for steroid hormone nuclear receptors to govern appropriate hormone action in target tissues. Male mice missing Fkbp52 are infertile, and this infertility has been ascribed to compromised sensitivity of the anterior prostate, external genitalia, and other accessory sex organs to androgen. Here, we show additional defects contributing to infertility. We found that epididymal Fkbp52−/− sperm are sparse often with aberrant morphology, and they have reduced fertilizing capacity. This phenotype, initially observed in null males on a C57BL/6/129 background, is also maintained on a CD1 background. Expression studies show that while FKBP52 and androgen receptor are co-expressed in similar cell types in the epididymis, FKBP52 is also present in epididymal sperm flagella. Collectively, our results suggest that reduced number and abnormal morphology contribute to compromised fertilizing capacity of Fkbp52−/− sperm. This study is clinically relevant because unraveling the role of immunophilin signaling in male fertility will help identify new targets for male contraceptives and/or alleviate male infertility.
Prognostic and Predictive Roles of High-Degree Microsatellite Instability in Colon Cancer: A National Cancer Institute–National Surgical Adjuvant Breast and Bowel Project Collaborative Study
Kim, George P., Colangelo, Linda H., Wieand, H. Samuel, Paik, Soonmyung , Allegra, Carmen J. , Kirsch, Ilan R. , Wolmark, Norman

Mayo Clinic

Journal of Clinical Oncology | January 17, 2007 | Volume: 25 | Issue: 7 | Pages: 767-772

10.1200/jco.2006.05.8172 | PMID 17228023 Get It

Purpose The role of high-degree microsatellite instability (MSI-H) as a marker to predict benefit from adjuvant chemotherapy remains unclear. Patients and Methods To help define its impact, we conducted an analysis of National Surgical Adjuvant Breast and Bowel Project (NSABP) patients who were randomly assigned to a surgery-alone group (untreated cohort) and patients assigned to an adjuvant fluorouracil (FU) -treated group (treated cohort). MSI-H and other potential markers were assessed (TGF-BRII, p53, thymidylate synthase, and Ki67). Results In all, 98 (18.1%) of 542 patients exhibited MSI-H, and there was a strong inverse relationship between MSI-H and mutant p53 status (P < .001). The prognostic analyses showed increased recurrence-free survival (RFS) for MSI-H patients versus MSS/MSI-L patients (P = .10), but showed no difference in overall survival (OS; P = .67). There was a potential interaction between MSI-H and mutant p53 in terms of improved RFS (P = .03). In the predictive marker analysis, we observed no interaction between MSI status and treatment for either RFS (P = .68) or OS (P = .62). Hazard ratios (HR) for RFS for MSI-H versus MSS/MSI-L patients were 0.77 (95% CI, 0.40 to 1.48) in the untreated-patients group and 0.60 (95% CI, 0.30 to 1.19) in the treated-patients group. HRs for OS were 0.82 (95% CI, 0.44 to 1.51) and 1.02 (95% CI, 0.56 to 1.85) for the respective groups. There was a trend toward improved RFS in patients with MSI-H and mutant p53. Conclusion These results do not support the use of MSI-H as a predictive marker of chemotherapy benefit.
Prognosis of Fibrotic Interstitial Pneumonia
Park, Joo Hun , Kim, Dong Soon, Park, I-Nae , Jang, Se Jin , Kitaichi, Masanori, Colby, Thomas V. , Nicholson, Andrew G.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | January 11, 2007 | Volume: 175 | Issue: 7 | Pages: 705-711

10.1164/rccm.200607-912oc | PMID 17218621 Get It

Abstract Background To investigate whether the better prognosis of interstitial pneumonias associated with collagen vascular disease (CVD) compared with idiopathic interstitial pneumonia (IIP) is due to higher frequency of the nonspecific interstitial pneumonia (NSIP) pattern in CVD, we compared the outcomes of patients from these two groups with the same histopathologic pattern. Subjects The clinical features and survival of 362 patients (269 with IIP and 93 with CVD) diagnosed using surgical lung biopsy were analyzed. Results The mean survival of the CVD group (131.0 mo) was longer than that of the IIP group (80.5 mo) (p &lt; 0.0001). The patients with usual interstitial pneumonia pattern among the CVD group (n = 36) was younger, female, and predominantly nonsmoking compared with the IIP group (n = 203). Although baseline lung functions were not significantly different, the CVD group survived longer (mean, 177.0 mo) than the IIP group (mean, 66.9 ± 6.5 mo; p = 0.001). By multivariate analysis, younger age, better pulmonary function, and the presence of a CVD were independent prognostic factors. In NSIP pattern, no significant differences in survival, clinical features, or lung function were found between the two groups. Conclusion Our data suggest that the better prognosis of patients in the CVD group is not solely due to the predominance of the NSIP pattern. The prognosis of patients with the usual interstitial pneumonia pattern in CVD is better than in those with idiopathic pulmonary fibrosis, despite the same pathologic pattern. In contrast, in those with an NSIP pattern, the prognosis is similar in both groups.
Insights into the mechanisms of action of anti‐Aβ antibodies in Alzheimer's disease mouse models
Levites, Yona , Smithson, Lisa, Price, Robert, Dakin, Rachel , Yuan, Bin , Kim, Jungsu , Reed, Dana Kim , Rosenberry, Terrone L. , Das, Pritam , Golde, Todd E. , Sierks, Michael R. , McGowan, Eileen , Kim, Jungsu

Mayo Clinic

The FASEB Journal | October 26, 2006 | Volume: 20 | Issue: 14 | Pages: 2576-2578

10.1096/fj.06-6463fje | PMID 17068112 Get It

A number of hypotheses regarding how anti‐Aβ antibodies alter amyloid deposition have been postulated, yet there is no consensus as to how Aβ immunotherapy works. We have examined the in vivo binding properties, pharmacokinetics, brain penetrance, and alterations in Aβ levels after a single peripheral dose of anti‐Aβ antibodies to both wild‐type (WT) and young non‐Aβ depositing APP and BRI‐Aβ42 mice. The rapid rise in plasma Aβ observed after antibody (Ab) administration is attributable to prolongation of the half‐life of Aβ bound to the Ab. Only a miniscule fraction of Ab enters the brain, and despite dramatic increases in plasma Aβ, we find no evidence that total brain Aβ levels are significantly altered. Surprisingly, cerebral spinal fluid Aβ levels transiently rise, and when Ab:Aβ complex is directly injected into the lateral ventricles of mice, it is rapidly cleared from the brain into the plasma where it remains stable. When viewed in context of daily turnover of Aβ, these data provide a framework to evaluate proposed mechanisms of Aβ attenuation mediated by peripheral administration of an anti‐Aβ monoclonal antibody (mAb) effective in passive immunization paradigm. Such quantitative data suggest that the mAbs are either indirectly enhancing clearance of Aβ or targeting a low abundance aggregation intermediate.—Levites, Y., Smithson, L. A., Price, R. W., Dakin. R. S., Yuan, B., Sierks, M. R., Kim, J., McGowan, E., Reed, D. K., Rosenberry, T. L., Das, P., Golde, T. E. Insights into the mechanisms of action of anti‐Aβ antibodies in Alzheimer's disease mouse models. FASEB J. 20, E2002–E2014 (2006)